125 | 0 | 35 |
下载次数 | 被引频次 | 阅读次数 |
慢性胰腺炎是一种胰腺的形态与功能均出现进行性、不可逆损伤的疾病。其病程中,炎症与纤维化过程可引发一系列严重的局部并发症,具体包括胰管结石、主胰管狭窄、胰腺假性囊肿、胆道狭窄、十二指肠梗阻、胰源性门静脉高压,严重时甚至可能进展为胰腺癌。与此同时,随着胰腺功能的逐渐丧失,患者还会出现内分泌及外分泌功能不全的情况。鉴于慢性胰腺炎并发症的复杂性与严重性,本文将对慢性胰腺炎并发症的诊疗进展展开综述,以期为临床实践提供有益的参考。
Abstract:Chronic pancreatitis is a disease characterized by irreversible changes in the morphology and function of the pancreas. During its course, the inflammatory and fibrotic processes can lead to a range of severe local complications, including pancreatic duct stones, main pancreatic duct stenosis, pancreatic pseudocysts, bile duct stenosis, duodenal obstruction, pancreatic portal hypertension, and in severe cases, even pancreatic cancer. Concurrently, as pancreatic function progressively deteriorates, patients may develop endocrine and exocrine insufficiency. Given the complexity and severity of the complications associated with chronic pancreatitis, this article will review the diagnostic and therapeutic advancements in the management of these complications, aiming to provide useful references for clinical practice.
[1] 中国医师协会胰腺病专业委员会慢性胰腺炎专委会.慢性胰腺炎诊治指南(2018,广州)[J].中华消化内镜杂志,2018,35(11):814-822.Pancreatology Speciality Committee of Chinese Medical Doctor Association.Guideline for the diagnosis and treatment of chronic pancreatitis (2018,Guangzhou) [J].Chin J Dig Endosc,2018,35(11):814-822.
[2] Li B Q,Liu X Y,Mao T,et al.The research progress of anti-inflammatory and anti-fibrosis treatment of chronic pancreatitis [J].Front Oncol,2022,12:1050274.
[3] Iyer S,Enman M,Sahay P,et al.Novel therapeutics to treat chronic pancreatitis:targeting pancreatic stellate cells and macrophages [J].Expert Rev Gastroenterol Hepatol,2024,18(4-5):171-183.
[4] Mederos M A,Reber H A,Girgis M D.Acute pancreatitis:a review [J].Jama,2021,325(4):382.
[5] Dalal A,Kamat N,Maydeo A,et al.Assessment of pancreatic ductal stone density on non-contrast computed tomography for predicting the outcome of extracorporeal shock wave lithotripsy [J].Endosc Int Open,2024,12(2):E274-E281.
[6] 黄强,刘振.胰管结石的诊疗策略[J].肝胆外科杂志,2022,30(1):5-8.
[7] Tez M,?ahing?z E,Martl? H F.Non-pharmacological pain palliation methods in chronic pancreatitis [J].World J Clin Cases,2023,11(35):8263-8269.
[8] Geusens D,van Malenstein H.The role of extracorporeal shock wave lithotripsy in the treatment of chronic pancreatitis [J].Acta Gastroenterol Belg,2021,84(4):620-626.
[9] Milovic V,Wehrmann T,Dietrich C F,et al.Extracorporeal shock wave lithotripsy with a transportable mini-lithotripter and subsequent endoscopic treatment improves clinical outcome in obstructive calcific chronic pancreatitis [J].Gastrointest Endosc,2011,74(6):1294-1299.
[10] Dominguez-Munoz J E,Drewes A M,Lindkvist B,et al.Corrigendum to ″Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis″ [J].Pancreatology,2020,20(1):148.
[11] Dumonceau J M,Delhaye M,Tringali A,et al.Endoscopic treatment of chronic pancreatitis:European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Updated August 2018 [J].Endoscopy,2019,51(2):179-193.
[12] Dominguez-Munoz J E,Drewes A M,Lindkvist B,et al.Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis [J].Pancreatology,2018,18(8):847-854.
[13] Tringali A,Bove V,Vadalà di Prampero S F,et al.Long-term follow-up after multiple plastic stenting for refractory pancreatic duct strictures in chronic pancreatitis [J].Endoscopy,2019,51(10):930-935.
[14] Liu Y,Wang D,Li Z S,et al.Treatment for refractory pancreatic duct strictures should follow the guidelines [J].Endoscopy,2020,52(2):155.
[15] Li T T,Song S L,Xiao L N,et al.Efficacy of fully covered self-expandable metal stents for the management of pancreatic duct strictures in chronic pancreatitis:a systematic review and meta-analysis [J].J Gastroenterol Hepatol,2020,35(7):1099-1106.
[16] Rodge G,Giri S,Kolhe K,et al.Fully covered self-expandable metallic stents for refractory benign pancreatic duct strictures:a systematic review and meta-analysis [J].Surg Laparosc Endosc Percutan Tech,2024,34(5):529-540.
[17] 安东均,安琳,张成,等.复杂胰管结石的腹腔镜手术与开腹手术疗效对比研究[J].中华腔镜外科杂志(电子版),2017,10(3):170-174.An D J,An L,Zhang C,et al.Comparative study of laparoscopic and open surgery for complicated pancreatic duct stones [J].Chin J Laparoscopic Surgery (Electronic Edition),2017,10(3):170-174.
[18] Quinn P L,Bansal S,Gallagher A,et al.Endoscopic versus laparoscopic drainage of pancreatic pseudocysts:a cost-effectiveness analysis [J].J Gastrointest Surg,2022,26(8):1679-1685.
[19] Hao W,Chen Y,Jiang Y,et al.Endoscopic versus laparoscopic treatment for pancreatic pseudocysts:a systematic review and meta-analysis [J].Pancreas,2021,50(6):788-795.
[20] Zerem E,Hauser G,Loga-Zec S,et al.Minimally invasive treatment of pancreatic pseudocysts [J].World J Gastroenterol,2015,21(22):6850-6860.
[21] Wang Z J,Song Y H,Li S Y,et al.Endoscopic management of pancreatic fluid collections with disconnected pancreatic duct syndrome [J].Endosc Ultrasound,2023,12(1):29-37.
[22] Jivani A,Shinde R K,Nagtode T,et al.The surgical management of pancreatic pseudocysts:a narrative review [J].Cureus,2024,16(9):e69055.
[23] Pan G,Wan M H,Xie K L,et al.Classification and management of pancreatic pseudocysts [J].Medicine (Baltimore),2015,94(24):e960.
[24] Suggs P,NeCamp T,Carr J A.A comparison of endoscopic versus surgical creation of a cystogastrostomy to drain pancreatic pseudocysts and walled-off pancreatic necrosis in 5500 patients [J].Ann Surg Open,2020,1(2):e024.
[25] Nassour I,Ramzan Z,Kukreja S.Robotic cystogastrostomy and debridement of walled-off pancreatic necrosis [J].J Robot Surg,2016,10(3):279-282.
[26] Cardenas A,Abrams A,Ong E,et al.Robotic-assisted cystogastrostomy for a patient with a pancreatic pseudocyst [J].J Robot Surg,2014,8(2):181-184.
[27] Elmunzer B J,Maranki J L,Gómez V,et al.ACG clinical guideline:diagnosis and management of biliary strictures [J].Am J Gastroenterol,2023,118(3):405-426.
[28] Sato T,Nakai Y,Fujishiro M.Current endoscopic approaches to biliary strictures [J].Curr Opin Gastroenterol,2022,38(5):450-460.
[29] 吴黎雳,乐金全,刘志恒,等.良性胆道狭窄的病因诊断策略和治疗方式选择[J].中国普通外科杂志,2023,32(2):296-308.Wu L L,Yue J Q,Liu Z H,et al.Strategy for etiological diagnosis and treatment choice of benign biliary stricture [J].China Journal of General Surgery,2023,32(2):296-308.
[30] Ramchandani M,Lakhtakia S,Costamagna G,et al.Fully covered self-expanding metal stent vs multiple plastic stents to treat benign biliary strictures secondary to chronic pancreatitis:a multicenter randomized trial [J].Gastroenterology,2021,161(1):185-195.
[31] Giri S,Jearth V,Sundaram S.Covered self-expanding metal stents versus multiple plastic stents for benign biliary strictures:an updated meta-analysis of randomized controlled trials [J].Cureus,2022,14(4):e24588.
[32] Ginestet C,Sanglier F,Hummel V,et al.EUS-guided biliary drainage with electrocautery-enhanced lumen-apposing metal stent placement should replace PTBD after ERCP failure in patients with distal tumoral biliary obstruction:a large real-life study [J].Surg Endosc,2022,36(5):3365-3373.
[33] Tang R S Y.Endoscopic evaluation of indeterminate biliary strictures:cholangioscopy,endoscopic ultrasound,or both?[J].Dig Endosc,2024,36(7):778-788.
[34] Ma M X,Jayasekeran V,Chong A K.Benign biliary strictures:prevalence,impact,and management strategies [J].Clin Exp Gastroenterol,2019,12:83-92.
[35] Ukegjini K,Steffen T,Tarantino I,et al.Systematic review on groove pancreatitis:management of a rare disease [J].BJS Open,2023,7(5):zrad094.
[36] Patel B N,Brooke Jeffrey R,Olcott E W,et al.Groove pancreatitis:a clinical and imaging overview [J].Abdom Radiol (NY),2020,45(5):1439-1446.
[37] Vila J J,Bolado F.Endoscopic management of local complications of chronic pancreatitis [J].Rev Esp Enferm Dig,2021,113(8):602-609.
[38] McClaine R J,Lowy A M,Matthews J B,et al.A comparison of pancreaticoduodenectomy and duodenum-preserving head resection for the treatment of chronic pancreatitis [J].HPB,2009,11(8):677-683.
[39] 李国煜,丛赟,何铁英.胰源性门静脉高压症发病机制及诊治的研究进展[J].肝胆胰外科杂志,2023,35(12):763-768.Li G Y,Cong Y,He T Y.The pathogenesis,diagnosis and treatment of portal hypertension caused by pancreatic disease [J].Journal of Hepatopancreatobiliary Surgery,2023,35(12):763-768.
[40] Latorre Fragua R A,Vázquez A M,López Marcano A J,et al.Pancreatic surgery in chronic pancreatitis complicated by extrahepatic portal hypertension or cavernous transformation of the portal vein:a systematic review [J].Scand J Surg,2020,109(3):177-186.
[41] Guixé-Muntet S,Quesada-Vázquez S,Gracia-Sancho J.Pathophysiology and therapeutic options for cirrhotic portal hypertension [J].Lancet Gastroenterol Hepatol,2024,9(7):646-663.
[42] 张长坤,李煜子,张龙辉,等.胰源性门静脉高压症诊治进展[J].中华肝脏外科手术学电子杂志,2022,11(1):13-16.Zhang C K,Li Y Z,Zhang L H,et al.Recent advance of diagnosis and treatment for sinistral portal hypertension [J].Chin J Hepat Surg (Electronic Edition),2022,11(1):13-16.
[43] Rudyk D V,Tutchenko M I,Chub S L,et al.Portal hypertension and emergency care [J].Wiad Lek,2024,77(7):1485-1489.
[44] Liu J,Wang Q,Ding X,et al.The clinical applicability of percutaneous splenic vein stent implantation for pancreatic portal hypertension [J].BMC Gastroenterol,2022,22(1):136.
[45] Pawlik T M.Pancreatic cancer [J].Surg Oncol Clin N Am,2021,30(4):xiii-xv.
[46] Karunakaran M,Barreto S G.Surgery for pancreatic cancer:current controversies and challenges [J].Future Oncol,2021,17(36):5135-5162.
[47] 中国抗癌协会胰腺癌专业委员会.中国抗癌协会胰腺癌整合诊治指南(精简版)[J].中国肿瘤临床,2023,50(20):1075.China Anti-Cancer Association Committee of Pancreatic Cancer.China Anti-Cancer Association guidelines for the holistic integrative management of pancreatic cancer(abridged version) [J].Chin J Clin Oncol,2023,50(20):1075.
[47] 中国抗癌协会胰腺癌专业委员会.中国抗癌协会胰腺癌整合诊治指南(精简版)[J].中国肿瘤临床,2023,50(10):487-496.China Anti-Cancer Association Committee of Pancreatic Cancer.China Anti-Cancer Association guidelines for the holistic integrative management of pancreatic cancer(abridged version) [J].Chin J Clin Oncol,2023,50(10):487-496.
[48] Torphy R J,Fujiwara Y,Schulick R D.Pancreatic cancer treatment:better,but a long way to go [J].Surg Today,2020,50(10):1117-1125.
[49] Mukherji R,Debnath D,Hartley M L,et al.The role of immunotherapy in pancreatic cancer [J].Curr Oncol,2022,29(10):6864-6892.
[50] Miyazawa M,Katsuda M,Kawai M,et al.Advances in immunotherapy for pancreatic ductal adenocarcinoma [J].J Hepato Biliary Pancreat Sci,2021,28(5):419-430.
[51] Kolbeinsson H M,Chandana S,Wright G P,et al.Pancreatic cancer:a review of current treatment and novel therapies [J].J Invest Surg,2023,36(1):2129884.
[52] Ewald N,Hardt P D.Diagnosis and treatment of diabetes mellitus in chronic pancreatitis [J].World J Gastroenterol,2013,19(42):7276-7281.
[53] Campagnola P,de Pretis N,Zorzi A,et al.Chronic pancreatitis and nutritional support [J].Best Pract Res Clin Gastroenterol,2023,62:101823.
[54] Vonderau J S,Desai C S.Type 3c:understanding pancreatogenic diabetes [J].JAAPA,2022,35(11):20-24.
[55] Wayne C D,Benbetka C,Besner G E,et al.Challenges of managing type 3c diabetes in the context of pancreatic resection,cancer and trauma [J].J Clin Med,2024,13(10):2993.
[56] Wu L,Nahm C B,Jamieson N B,et al.Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy:a systematic review [J].Clin Endocrinol,2020,92(5):396-406.
[57] Kumar P P,Rao G V,Shetty M,et al.Understanding the structural arrangement of islets in chronic pancreatitis [J].J Histochem Cytochem,2024,72(1):25-40.
[58] Jarlborg P,Jornayvaz F R.Pancreatogenic diabetes [J].Rev Med Suisse,2022,18(784):1090-1095.
[59] Diéguez-Castillo C,Jiménez-Luna C,Martín-Ruiz J L,et al.Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis [J].J Clin Med,2020,9(6):2014.
[60] 史晨光.PERT治疗胰腺外分泌功能不全的安全和有效性:Meta分析 [D].太原:山西医科大学,2021.
[61] Min M,Patel B,Han S,et al.Exocrine pancreatic insufficiency and malnutrition in chronic pancreatitis:identification,treatment,and consequences [J].Pancreas,2018,47(8):1015-1018.
[62] Freswick P N,Reid E K,Mascarenhas M R.Pancreatic enzyme replacement therapy in cystic fibrosis [J].Nutrients,2022,14(7):1341.
[63] Krishnamurty D M,Rabiee A,Jagannath S B,et al.Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis [J].Ther Clin Risk Manag,2009,5(3):507-520.
[64] Shimizu K,Ito T,Irisawa A,et al.Evidence-based clinical practice guidelines for chronic pancreatitis 2021 [J].J Gastroenterol,2022,57(10):709-724.
[65] Zhou Y,Huang R Q,Wu Q W,et al.Adherence to pancreatic enzyme replacement therapy among patients with chronic pancreatitis in East China:a mixed methods study [J].Sci Rep,2023,13(1):17147.
[66] Capurso G,Tranin M,Piciucchi M,et al.Exocrine pancreatic insufficiency:prevalence,diagnosis,and management [J].Clin Exp Gastroenterol,2019,12:129-139.
[67] Lewis D M,Rieke J G,Almusaylim K,et al.Exocrine pancreatic insufficiency dosing guidelines for pancreatic enzyme replacement therapy vary widely across disease types [J].Dig Dis Sci,2024,69(2):615-633.
[68] Cridge H,Williams D A,Barko P C.Exocrine pancreatic insufficiency in dogs and cats [J].J Am Vet Med Assoc,2024,262(2):246-255.
基本信息:
DOI:
中图分类号:R576
引用信息:
[1]刘文静,李明阳.慢性胰腺炎并发症的诊疗进展[J].胃肠病学和肝病学杂志,2025,34(09):1252-1257.
基金信息: